We examined the localization of oestrogen receptor (ER) β mRNA in the human endometrium throughout the menstrual cycle using non-radioactive in-situ hybridization with Brigati-tailed oligonucleotides. The findings were compared with those of ERα in order to examine the possible biological significance of ERβ in the human endometrium. Both ERα and ERβ mRNA expression were detected in all major human uterine cell types, including glandular epithelial cells, stromal cells and smooth muscle cells of the uterine wall, at every menstrual cycle stage. However, ERα mRNA expression was more prominent than that of ERβ in all cell types throughout the menstrual cycle. In proliferative phase endometrium, ERα mRNA was expressed in both glandular epithelial and stromal cells, while ERβ mRNA was expressed predominantly in glandular epithelial cells. Although the same pattern was observed in the secretory phase, both the ERα and ERβ mRNA expression was relatively weaker. These results suggest that oestrogenic effects occur predominantly through ERα, but that ERβ may also play a role in the modulation of oestrogenic action, especially on glandular epithelial cells in the human endometrium throughout the menstrual cycle.
Introduction
Oestrogens play important roles in the regulation of the menstrual cycle in human endometrium and these oestrogenic effects were thought to act via a single oestrogen receptor (ER)α. Since the cloning of classical ER (or ERα) cDNA (Greene et al., 1986) and the production of specific monoclonal antibodies against the ERα protein, numerous studies have demonstrated the expression of ERα mRNA (Parl et al., 1987; Koji and Brenner, 1993) and protein (Press et al., 1984; Bergerone et al., 1988; Lessey et al., 1988) in human uterus throughout the menstrual cycle. However, with the recent cloning of a novel oestrogen receptor ERβ (Kuiper et al., 1996; Mosselman et al., 1996; Tremblay et al., 1997) , some of these oestrogenic effects may occur through this newly identified receptor. ERβ mRNA in uterine tissues has been studied by several groups using reverse transcription -polymerase chain reaction (RT-PCR) and/or Northern blot analysis (Kuiper et al., 1996; Mosselman et al., 1996; Enmark et al., 1997; Tremblay et al., 1997) , which demonstrated that ERβ mRNA concentrations were much lower than those of ERα mRNA. A recent study has demonstrated ERβ mRNA in the human endometrium, regardless of the cycle phase, using RT-PCR analysis (Rey et al., 1998) . As the endometrium is composed of both glandular epithelial and stromal cells, it is very important to study the localization of ERβ mRNA expression in the endometrium to clarify its possible biological roles. The localization of ERβ expression has not been examined in human endometrium. In this study we examined 
Oligonucleotide probes
The sequence of antisense ER oligonucleotide probes employed for mRNA in-situ hybridization were; ERα: 5Ј-CAG CTC GTT CCC TTG GAT CTG ATG CAG TAG-3Ј and ERβ: 5Ј-TGT TGG CCA CAA CAC ATT TGG GCT TGT GGT-3Ј, which correspond to nucleotides 332-361 (Greene et al., 1986) and 76-105 (Mosselman et al., 1996) of ERα and ERβ sequences respectively. The probes had similar GC-contents and were selected from the N-terminal A/B domain (Sasano et al., 1998) . Sense oligonucleotides, complementary to the antisense probes, were used as negative control probes; ERα: 5Ј -CTA CTG CAT CAG ATC CAA GGG AAC GAG CTG-3Ј and ERβ: 5Ј-ACC ACA AGC CCA AAT GTG TTG TGG CCA ACA-3Ј. All oligonucleotide probes were synthesized with a 3Ј-biotinylated tail [Brigati tail (Iino et al., 1997; Sasano et al., 1997) ; 5Ј-probebiotin-biotin-biotin-TAG-TAG-biotin-biotin-biotin-3Ј]. Both the ERα and ERβ probes demonstrated no significant sequence similarity to each other, or to other known human gene sequences, including glucocorticoid, mineralcorticoid or progesterone receptors as assessed by a Genbank database search.
In-situ hybridization
In-situ hybridization was performed using of a manual capillary action system (MicroProbe staining system, Fisher Scientific, Pittsburgh, PA, USA) with a modification of previously reported methods (Iino et al., 1997; Sasano et al., 1997) . Tissue sections were rapidly dewaxed, cleared, with alcohol, rehydrated with a Tris-based buffer, pH 7.4 (Universal Buffer; Research Genetics, Huntsville, AL, USA), and digested with pepsin (2.5 mg/ml; Research Genetics) for 4 min at 105°C. The probe was applied in formamide-free diluent, slides heated to 105°C for 3 min, cooled for~1 min at room temperature and allowed to hybridize at 45°C for 45 min. The sections were then washed three times with 2ϫ sodium chloride/sodium citrate (SSC) solution at room temperature and incubated with alkaline phosphataseconjugated streptavidin (Research Genetics). After washing three times in alkaline phosphatase chromogen buffer, pH 9.5 (Research Genetics), at room temperature, hybridization signals were visualized using fast red salt. Slides were counterstained with haematoxylin, air-560 dried, and covered with coverslips for microscopic examination. Negative control experiments were performed using sense probes. As positive control tissues for ERβ, fetal kidney tissues were used, in which moderate expression of ERβ mRNA had been previously demonstrated by RT-PCR (Brandenberger et al., 1997) .
The relative strengths of mRNA hybridization signals were independently evaluated by two of the authors (S.M. and H.S.) and classified as (-); no hybridization signal, (Ϯ); very weak, (ϩ); weak, (ϩϩ); moderate, (ϩϩϩ); strong. Discordant cases were re-evaluated together (S.M. and H.S.).
Immunohistochemistry
Immunohistochemical staining was performed using the monoclonal antibody, ER1D5 (Immunotech, Marseille, France), which was generated against the A/B domain of ERα (Al Saati et al., 1993) . Immunohistochemical procedures were as previously reported (Sasano et al., 1994 (Sasano et al., , 1996 . Autoclave treatment in citric acid buffer at 120°C for 5 min was employed for tissue antigen retrieval. Negative controls were performed by replacing primary antibody with normal mouse immunoglobulin (Ig)G diluted at the same concentration as the primary antibody and no specific immunoreactivity was detected. As positive controls, tissue sections of ERα-positive breast cancer were used. To quantify immunopositivity, immunoreacted cells were counted separately in the functionalis and basalis of the endometrium, using a semi-automatic computerized image analysis system. The computerized image analysis system consisted of a light microscope (Zeiss, Göttingen, Germany) (ϫ40 objective, ϫ10 ocular) with a colour charge coupling device camera (Zeiss) connected to a Macintosh 9500/120 computer. For each section, the number of positive glandular and stromal cells was counted, regardless of the staining intensity, in a total of 10 non-overlapping areas. Results were expressed as (-); no positive cells, (Ϯ); 0-5%, (ϩ); 5-25%, (ϩϩ); 25-50%, (ϩϩϩ); 50-75%, (ϩϩϩϩ); Ͼ75% of positive cells.
Results
Results are summarized in Tables I (in-situ 
Proliferative phase
Both glandular epithelial and stromal cells demonstrated marked expression of ERα mRNA (Figure 1a) . ERβ mRNA expression, however, was predominantly detected in glandular epithelial cells and weakly in stromal cells (Figure 1b) . Patterns of ERα and ERβ mRNA localization were not different between the functionalis and basalis. The lowermost layer of the endometrium is the basalis and the overlying one the functionalis. The basalis is a zone of weakly proliferative glands and associated dense spindled stroma immediately adjacent to the myometrium (Hendrickson and Kempson, 1991) . ERβ mRNA expression in glandular epithelial cells was weak compared with that of ERα.
Secretory phase
From early to late secretory phase, ERα mRNA concentrations in the glandular epithelial cells became markedly low in the functionalis, whereas ERα mRNA concentrations in the basalis remained similar to those observed in the proliferative phase. ERα mRNA hybridization signals in the stromal cells also became less prominent than those during the proliferative phase, but stromal cells adjacent to the secretory glands and in the basalis retained the same hybridization signal intensity (Figure 1d,g ). ERβ mRNA expression in glandular epithelial and stromal cells was also markedly decreased in the functionalis with the progression of the secretory phase. In the late secretory phase, ERβ mRNA concentrations in the glandular epithelial and stromal cells became barely discernible or absent in the functionalis (Figure 1e ) and retained very weakly in the basalis (Figure 1h ). Throughout the menstrual cycle, ERβ mRNA expression in the glandular epithelial cells remained much weaker than that of ERα.
Myometrium
In the myometrium, relatively weak ERα and ERβ mRNA hybridization signals were detected in smooth muscle cells, and no change in their relative intensities and localization patterns were observed throughout the menstrual cycle. However, at every stage, ERα mRNA expression was more prominent than that of ERβ.
Immunohistochemistry for ERα
During the proliferative phase, both glandular epithelial and stromal cells demonstrated marked nuclear immunoreactivity and intensity of staining was not different between functionalis and basalis (Figure 2a,b) . During the secretory phase, the number of ERα-positive cells decreased markedly in both glandular epithelial and stromal cells of the functionalis but remained similar in the basalis (Figure 2c,d ). ERα nuclear 562 immunoreactivity was detected in smooth muscle cells of the myometrium at each stage of the menstrual cycle.
Controls
No significant hybridization signals were detected when sections were hybridized with either ERα or ERβ sense probes (Figure 1c,f,i) . Significant hybridization signals were detected when sections of fetal kidney were hybridized with the ERβ antisense probe, whereas no significant hybridization signals were detected when they were hybridized with the ERα antisense probe.
Discussion
Our results demonstrated the localization of ERα and ERβ mRNA expression in the human endometrium in agreement with previous study using RT-PCR, which demonstrated the presence of both ERα and ERβ mRNAs (Rey et al., 1998) . ERα mRNA expression was localized in glandular epithelial and stromal cells with marked cyclic change, which is consistent with another previous study (Koji and Brenner, 1993) . ERβ mRNA expression was detected in glandular epithelial and stromal cells as well as in myometrial smooth muscle cells. Cyclic change of ERβ mRNA expression was less evident compared with that of ERα mRNA expression. In addition, ERβ mRNA was expressed predominantly in glandular epithelial cells. Although both ERα and ERβ mRNA expression patterns in glandular epithelial and stromal cells of the endometrium were similar throughout the menstrual cycle, ERα mRNA expression was more prominent than that of ERβ. The intensity of ERβ mRNA hybridization signals in stromal cells was always much weaker than that of ERα. In-situ hybridization has some unavoidable limitations in terms of quantification and comparison of signal intensities between different genes and may, therefore, be difficult. Various technical factors such as duration of fixation, types of fixatives employed (Koji and Brenner, 1993) and probe labelling efficiency may affect the intensity of mRNA hybridization signals. To minimize the possible technical problems, we performed in-situ hybridization for ERα and ERβ mRNA on serial sections at the same time in the same manner. We verified the labelling efficiency for ERα and ERβ, using fetal kidney tissues as positive controls for ERβ. Results of these studies suggested that there were only minimal differences of the probe labelling efficiency between ERα and ERβ. The present findings suggest that oestrogenic effects occur predominantly through ERα, but ERβ may also play some role in the modulation of oestrogenic action, especially on glandular epithelial cells in human uterine tissues. In the present study we demonstrated that the expression of ERα mRNA parallels that of ERα protein. Further investigations are required to examine ERα and ERβ in protein concentrations in various cell types.
ERβ is thought to be functional in vitro as it interacts with both oestrogens and anti-oestrogens, and activates transcription of oestrogen response element (ERE)-containing promoters (Mosselman et al., 1996) . In addition, ERβ protein has a high affinity for oestradiol, as does the ERα . However, the uterus of the oestrogen receptor knock-out (ERKO) mice, in which the ERα but not the ERβ gene was disrupted (Couse et al., 1997) , demonstrated no response to oestradiol treatment (Lubahn et al., 1993; Couse et al., 1995) . One possible explanation for this lack of oestradiol responsiveness is that heterodimerization of ERα and β is required for transcription activation in uterine tissues. ERα and ERβ can form heterodimers upon binding to the oestrogen response elements both in vitro and in vivo (Pace et al., 1997; Ogawa et al., 1998) . We demonstrated that ERα and ERβ are coexpressed in glandular epithelial cells with similar marked cyclic changes in the uterus, suggesting that both ERs may be involved in the regulation of oestrogen-responsive gene expression. It will be important to examine whether ERα and ERβ proteins are co-expresed in a single cell. Another possible explanation is that signalling from an ERβ-dependent AP-1 element may occur in ERKO mouse uterus. A recent study demonstrated that ERα and ERβ signal in different ways depending on ligands and response elements (Paeh et al., 1997) . Both in Ishikawa cells (a human uterine cell line) and in human breast cancer cells, synthetic anti-oestrogens, including tamoxifen, raloxifen and ICI164384, activated an ERβ-dependent AP-1 site. In contrast, oestrogens (including 563 17β-oestradiol and diethylstilboestrol) inhibited the ERβ-dependent AP-1 site (Paeh et al., 1997) . If signalling from an ERβ-dependent AP-1 site occurs in uterine tissues, ERβ may play an important role in mechanism to control ERα-mediated effects.
In conclusion, our findings suggest that ERβ may play some functional role in human endometrium throughout the menstrual cycle. However, further studies, including the analysis using quantitative PCR, are required to clarify the biological roles of ERβ in human endometrium.
